Latest Security News

Chrysos Corporation reports nearly one million monthly PhotonAssay samples and reiterates strong FY26 revenue guidance, while unveiling next-gen assay technologies and global expansion plans.

Chrysos Corporation reported robust FY25 results driven by record sample volumes and expanded global deployments of its PhotonAssay technology. The company reiterates strong FY26 guidance amid growing international partnerships.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.

Andromeda Metals has initiated early site works at its Great White Project following the lodgement of a $3.79 million rehabilitation bond and environmental compliance payments. This milestone marks a key step toward advancing the project’s development in South Australia.

Rox Resources (ASX – RXL) has delivered a comprehensive update on its Youanmi Gold Project, highlighting a compelling Definitive Feasibility Study and significant funding progress that set the stage for production in 2026.

Comms Group has secured a new $10.7 million refinancing package with improved terms, including additional funding capacity for acquisitions and equipment finance. This move aims to enhance financial flexibility and support future growth initiatives.

Skylark Minerals has acquired a high-grade gold portfolio in Côte d'Ivoire, including a flagship project with a 364,600-ounce inferred resource, marking a significant step in its West African growth strategy. The company is fully funded to accelerate exploration in early 2026, targeting resource expansion and new discoveries.

Genmin Limited has successfully completed the first tranche of its capital raising, issuing over 131 million shares to fund its flagship Baniaka iron ore project in Gabon, targeting production by late 2026.

Magnetite Mines has cleared a crucial regulatory hurdle as its Razorback Iron Ore Project’s Mining Lease Proposal passes the South Australian Government’s validity assessment, paving the way for detailed technical review and public consultation.

Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.

Chimeric Therapeutics has received a $4.5 million R&D tax incentive refund from the Australian Government, underscoring its ongoing investment in innovative cancer cell therapies.

VHM Limited has raised A$10.3 million through a fully-underwritten institutional placement, advancing its Goschen Project development ahead of a Final Investment Decision in early 2026. A Share Purchase Plan will follow, inviting existing shareholders to participate at the same discounted price.